Our previous study showed that lncRNA H19 suppression protected the endothelium against hyperglycemia-induced inflammation and oxidative stress by upregulating miR-29b expression and downregulating VEGFA expression, which caused the activation of the AKT/eNOS pathway in endothelial cells [11]. The gene discussed is AKT1; the disease is Hyperglycemia.